Cite
Aoyama T, Kawabe T, Fujikawa H, et al. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015;22:S1616doi: 10.1245/s10434-015-4732-8.
Aoyama, T., Kawabe, T., Fujikawa, H., Hayashi, T., Yamada, T., Tsuchida, K., Yukawa, N., Oshima, T., Rino, Y., Masuda, M., Ogata, T., Cho, H., & Yoshikawa, T. (2015). Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Annals of surgical oncology, 22S1616. https://doi.org/10.1245/s10434-015-4732-8
Aoyama, Toru, et al. "Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer." Annals of surgical oncology vol. 22 (2015): S1616. doi: https://doi.org/10.1245/s10434-015-4732-8
Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015 Dec;22:S1616. doi: 10.1245/s10434-015-4732-8. PMID: 26170193.
Copy
Download .nbib